@article{6b2084c048ef44e5867847b7d15f9571,
title = "An analysis of the costs and treatment success of etanercept in juvenile idiopathic arthritis: results from the Dutch Arthritis and Biologicals in Children register",
keywords = "Juvenile idiopathic arthritis, Paediatric rheumatology, National register study, Etanercept, Tumour necrosis factor-alpha, Biologic, Treatment costs, Cost-effectiveness, Cost-utility, Health utilities index",
author = "Prince, {Femke H. M.} and {de Bekker-Grob}, {Esther W.} and Marinka Twilt and {van Rossum}, {Marion A. J.} and Hoppenreijs, {Esther P. A. H.} and {ten Cate}, Rebecca and Yvonne Koopman-Keemink and Gorter, {Simone L.} and Hein Raat and {van Suijlekom-Smit}, {Lisette W. A.}",
year = "2011",
month = jun,
doi = "10.1093/rheumatology/keq432",
language = "English",
volume = "50",
pages = "1131--1136",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",
number = "6",
}